Keros Therapeutics, Inc.·4

Sep 5, 4:10 PM ET

Seehra Jasbir 4

4 · Keros Therapeutics, Inc. · Filed Sep 5, 2025

Insider Transaction Report

Form 4
Period: 2025-09-03
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Common Stock

    2025-09-03+90,500392,723 total
Footnotes (1)
  • [F1]Represents a restricted stock unit ("RSU") award. The RSUs vest as follows: 25% of the RSUs shall vest on each of February 18, 2026, February 18, 2027, February 18, 2028 and February 18, 2029, in each case, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    form4-09052025_040903.xmlPrimary